How do we balance the speed of developing new drugs with the confidence of knowing they really work? In Bioethics & Drug Regulation, Greenwall Faculty Scholar, Holly Fernandez Lynch, JD, explains how bioethics can help draw attention to the tradeoffs at the heart of FDA decision-making and inform policy that supports both high-quality research and facilitates access to new drugs for patients who might benefit from them even before they’ve been approved.